Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 23, 1694-1700, November 1, 1963]
© 1963 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pitot, H. C.
Right arrow Articles by Heidelberger, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pitot, H. C.
Right arrow Articles by Heidelberger, C.

Metabolic Regulatory Circuits and Carcinogenesis

Henry C. Pitot and Charles Heidelberger*

( McArdle Memorial Laboratory, The Medical School, University of Wisconsin, Madison, Wisconsin)

Recent studies on the control of enzyme synthesis and activity in microorganisms which have been carried out largely in the laboratory of Jacob and Monod in Paris have led to the formulation of a model which in its general form agrees with much of the known experimental data. Basically, the genetic apparatus for enzyme synthesis is thought to consist of regulator genes which produce cytoplasmic products known as repressors and an operon consisting of an operator and structural genes. The product of the regulator gene together with small molecular weight, usually exogenous, regulators interacts with the operator gene to control the expression of the entire operon. This basic circuit may be modified in a number of ways to produce an equally varied number of phenotypes. Several of these phenotypes may be perpetuated by a short exposure of the regulator, here thought of as a carcinogen, to the system. Such a picture fits the known concepts of chemical carcinogenesis and shows in a theoretical manner how a malignant cell may be produced in the absence of a genetic (DNA) change. If malignancy is not the result of a direct gene (DNA) mutation, a reversion from the malignant to the nonmalignant state is well within reason.

* American Cancer Society Professor of Oncology.

Received 6/25/63.


This article has been cited by other articles:


Home page
ScienceHome page
C. W. Abell, H. L. Falk, M. B. Shimkin, E. K. Weisburger, J. H. Weisburger, and N. Gubareff
Uracil Mustard: A Potent Inducer of Lung Tumors in Mice
Science, March 19, 1965; 147(3664): 1443 - 1445.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1963 by the American Association for Cancer Research.